 |
|
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
Jiwoong Yu, Hyun Hwan Sung
J Urol Oncol. 2023;21(3):228-240. Published online 2023 Nov 30 DOI: https://doi.org/10.22465/juo.234600420021
|
|
Citations to this article as recorded by
 Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea
Gang Kyu Kim, Young Heun Jo, Jongsoo Lee, Hyun Ho Han, Won Sik Ham, Won Sik Jang, Ji Eun Heo
Investigative and Clinical Urology.2024; 65(5): 435. CrossRef Summarizing the Intentions and Outcomes of JUO 2023 Issue 3
Cheol Kwak
Journal of Urologic Oncology.2023; 21(3): 181. CrossRef
|